Translation Inhibitors as Therapeutic Strategy

Cure Research with a Heart Translation inhibitors may be part of a therapeutic strategy by Jeannie Wraight To date there are over 100 documented cases of HIV...

Targeting HIV Reservoirs

Hiding Place One focus of the amfAR 2016 CURE Summit targeted HIV reservoirs by Jeannie Wraight This year, amfAR marked World AIDS Day with the 2016 HIV...

HTVN 702: Vaccine Candidate

Step Forward Vaccine candidates like HTVN 702 are needed to build momentum by Jeannie Wraight If current HIV diagnoses rates persist, about 1 in 2 black men...

Good News, Bad News

LifeGuide Good News, Bad News The HIV cure front faces disappointment mixed with hope by Jeannie Wraight The past year has been a difficult one in the HIV...

Countdown to a Cure

by Jeannie Wraight As part of the Countdown to a Cure Initiative, amfAR (The Foundation for AIDS Research) will direct $20 million, of a $100...
A&U America's AIDS Magazine

Cure—Or Bust

LifeGuide Cure—or Bust Amid advances and setbacks in care, we must still aim for the end of HIV by Jeannie Wraight   I recently read a rather angry reader...

Cure Research: CROI 2018

Fast Look Cure research highlights from CROI 2018 by Jeannie Wraight The Conference on Retroviruses and Opportunistic Infections (CROI) provides an annual snapshot of the year’s most...

JAK Inhibitors

JAK of All Trades Researchers look to JAK inhibitors as part of hiv treatment & eradication by Jeannie Wraight R research on three Janus kinase inhibitors (JAK...

Trump Strives to End HIV, But at Whose Expense?

A Plan for America The Trump administration strives to end the HIV epidemic, but at whose expense? by Jeannie Wraight In this month’s Destination: Cure I’m going...

Expediting Research

GlaxoSmithKline (GSK) and the University of North Carolina at Chapel-Hill (UNC) will launch a jointly owned novel HIV Cure Center, as well as a...

LATEST POSTS

ViiV’s Dolutegravir Dual Therapy Works for Both First-Line & Maintenance Treatment

ViiV’s Dolutegravir Dual Therapy Works for Both First-Line & Maintenance Treatment Findings from the GEMINI and TANGO studies, reported at the 10th International AIDS Society...

5B, or Not to 5B

Jason Bennett: Advocate